New severe hemorrhagic events during the first 28 days in patients with moderate bleeding at initial diagnosis
| Initial therapy . | No. (%) of patients with moderate bleeding at diagnosis . | No. (%) of such patients with new severe bleeding episode before day 28 . |
|---|---|---|
| IVIG | 42 (24) | 0 |
| Corticosteroids | 47 (27) | 1 |
| Anti-D immunoglobulin | 10 (6) | 1 |
| No drug therapy | 19 (11) | 0 |
| Multiple drug treatments/other | 55 (32) | 1 |
| Total | 173 | 3 (1.7%) |
| Initial therapy . | No. (%) of patients with moderate bleeding at diagnosis . | No. (%) of such patients with new severe bleeding episode before day 28 . |
|---|---|---|
| IVIG | 42 (24) | 0 |
| Corticosteroids | 47 (27) | 1 |
| Anti-D immunoglobulin | 10 (6) | 1 |
| No drug therapy | 19 (11) | 0 |
| Multiple drug treatments/other | 55 (32) | 1 |
| Total | 173 | 3 (1.7%) |